TY - JOUR
T1 - Nutraceuticals in canine liver disease: assessing the evidence
AU - Vandeweerd, Jean-Michel
AU - Cambier, Carole
AU - Gustin, Pascal
PY - 2013/9
Y1 - 2013/9
N2 - Nutraceuticals, or nutritional supplements, have been promoted for the ancillary treatment of liver disease in dogs. However, minimal information is available in the scientific literature about commonly used nutraceuticals, such as S-adenosylmethionine, silymarin, and vitamin E. No strong clinical evidence exists regarding the efficacy of these compounds as hepatoprotectants in canine liver disease. Until this evidence exists, individual veterinarians must assume responsibility for their decision to use nutritional supplements in their canine patients with liver disease. © 2013 Elsevier Inc.
AB - Nutraceuticals, or nutritional supplements, have been promoted for the ancillary treatment of liver disease in dogs. However, minimal information is available in the scientific literature about commonly used nutraceuticals, such as S-adenosylmethionine, silymarin, and vitamin E. No strong clinical evidence exists regarding the efficacy of these compounds as hepatoprotectants in canine liver disease. Until this evidence exists, individual veterinarians must assume responsibility for their decision to use nutritional supplements in their canine patients with liver disease. © 2013 Elsevier Inc.
KW - Dietary supplement
KW - Evidence
KW - Liver
KW - Nutraceuticals
UR - http://www.scopus.com/inward/record.url?scp=84880930916&partnerID=8YFLogxK
U2 - 10.1016/j.cvsm.2013.05.003
DO - 10.1016/j.cvsm.2013.05.003
M3 - Article
SN - 0195-5616
VL - 43
SP - 1171
EP - 1179
JO - Veterinary Clinics of North America - Small Animal Practice
JF - Veterinary Clinics of North America - Small Animal Practice
IS - 5
ER -